Title: STAT3 Regulates Mitochondrial Gene Expression in Pancreatic beta-Cells and Its Deficiency Induces Glucose Intolerance in Obesity
Authors: Schaschkow, A
Pang, L
Vandenbempt, V
Elvira, B
Litwak, SA
Vekeriotaite, B
Maillard, E
Vermeersch, M
Paula, FMM
Pinget, M
Perez-Morga, D
Gough, DJ
Gurzov, EN
Issue Year: 2021
Publisher AMER DIABETES ASSOC
Series DIABETES:
Abstract Most obese and insulin-resistant individuals do not develop diabetes. This is the result of the capacity of beta -cells to adapt and produce enough insulin to cover the needs of the organism. The underlying mechanism of beta -cell adaptation in obesity, however, remains unclear. Previous studies have suggested a role for STAT3 in mediating beta -cell development and human glucose homeostasis, but little is known about STAT3 in beta -cells in obesity. We observed enhanced cytoplasmic expression of STAT3 in severely obese subjects with diabetes. To address the functional role of STAT3 in adult beta -cells, we generated mice with tamoxifen-inducible partial or full deletion of STAT3 in beta -cells and fed them a high-fat diet before analysis. Interestingly, beta -cell heterozygous and homozygous STAT3-deficient mice showed glucose intolerance when fed a high-fat diet. Gene expression analysis with RNA sequencing showed that reduced expression of mitochondrial genes in STAT3 knocked down human EndoC-beta H-1 cells, confirmed in FACS-purified beta -cells from obese STAT3-deficient mice. Moreover, silencing of STAT3 impaired mitochondria activity in EndoC-beta H-1 cells and human islets, suggesting a mechanism for STAT3-modulated beta -cell function. Our study postulates STAT3 as a novel regulator of beta -cell function in obesity.
URI: https://publications.svi.edu.au/publications/8219
Other Identifiers 10.2337/db20-1222
Publication type Article